期刊
TRANSPLANT INTERNATIONAL
卷 26, 期 6, 页码 576-589出版社
WILEY
DOI: 10.1111/tri.12081
关键词
cellular therapy; clinical trials; immune regulation; regulatory T cell; tolerance; transplantation
资金
- Wellcome Trust
- Medical Research Council UK
- British Heart Foundation
- Roche Organ Transplant Research Foundation
- Restore
- Burn and Wound Research Trust
- European Union
- British Heart Foundation [FS/12/72/29754] Funding Source: researchfish
- Medical Research Council [G0800842] Funding Source: researchfish
- National Institute for Health Research [ACF-2013-18-020] Funding Source: researchfish
- MRC [G0800842] Funding Source: UKRI
Since the first solid organ transplant between the Herrick twins in 1954, transplantation immunology has sought to move away from harmful immunosuppressive regimens towards tolerogenic strategies that promote long-term graft survival. This has required a concerted multinational effort with scientists and clinicians working towards a common goal. Reports of immunosuppression-free kidney and liver allograft recipients have provided the proof-of-principle, but intentional generation of tolerance in clinical transplantation is still only achieved infrequently. Recently, there have been an increasing number of encouraging developments in the field in both experimental and clinical studies. In this article, we review the latest advances in tolerance research and consider possible future barriers and solutions in achieving reliable graft acceptance in the long term.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据